Uccelli Antonio, Moretta Lorenzo, Pistoia Vito
Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Italy.
Nat Rev Immunol. 2008 Sep;8(9):726-36. doi: 10.1038/nri2395.
Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can be isolated from many adult tissues. They can differentiate into cells of the mesodermal lineage, such as adipocytes, osteocytes and chondrocytes, as well as cells of other embryonic lineages. MSCs can interact with cells of both the innate and adaptive immune systems, leading to the modulation of several effector functions. After in vivo administration, MSCs induce peripheral tolerance and migrate to injured tissues, where they can inhibit the release of pro-inflammatory cytokines and promote the survival of damaged cells. This Review discusses the targets and mechanisms of MSC-mediated immunomodulation and the possible translation of MSCs to new therapeutic approaches.
间充质干细胞(MSCs)是基质干细胞的一个异质性亚群,可从多种成人组织中分离得到。它们能够分化为中胚层谱系的细胞,如脂肪细胞、骨细胞和软骨细胞,以及其他胚胎谱系的细胞。MSCs可与先天性和适应性免疫系统的细胞相互作用,从而调节多种效应功能。在体内给药后,MSCs可诱导外周耐受并迁移至受损组织,在那里它们能够抑制促炎细胞因子的释放并促进受损细胞的存活。本综述讨论了MSCs介导的免疫调节的靶点和机制,以及MSCs在新治疗方法中的可能应用。